Prof. Dr. AZİME ŞEBNEM SOYSAL ACAR

Desteklenen Projeler

• 2020 - 2025 An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension

  Diğer Ülkelerdeki Özel Organizasyonlar Tarafından Desteklenmiş Proje

  Soysal Acar A. Ş., Demir E.